Assessing thyroid cancer risk using polygenic risk scores

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: 2020-03-04

DOI: 10.1073/pnas.1919976117

Affiliations: 26

Authors: 21

Go to article
Institutions Share
deCODE Genetics, Inc., Iceland 0.19
Landspitali - The National University Hospital of Iceland, Iceland 0.11
OSU Division of Endocrinology, Diabetes and Metabolism, United States of America (USA) 0.10
OSU Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James), United States of America (USA) 0.10
Radboud Institute for Health Sciences (RIHS), RU, Netherlands 0.07
Radboud Institute for Molecular Life Sciences (RIMLS), RU, Netherlands 0.05
Department of Epidemiology, MD Anderson Cancer Center, United States of America (USA) 0.05
Department of Head and Neck Surgery, MD Anderson Cancer Center, United States of America (USA) 0.05
Faculty of Medicine, University of Iceland, Iceland 0.04
OSU College of Medicine, United States of America (USA) 0.04
OSU Department Cancer Biology and Genetics, United States of America (USA) 0.04
UMC Department of Cardiology, Netherlands 0.03
Department of Internal Medicine, RU, Netherlands 0.02
UCHealth Diane O’Connor Thompson Breast Center, United States of America (USA) 0.02
University of Colorado Hospital (UCH), United States of America (USA) 0.02
OSU Department of Internal Medicine, United States of America (USA) 0.02
Icelandic Cancer Registry (ICR), Iceland 0.02
UCL Institute of Cardiovascular Science (ICS), United Kingdom (UK) 0.01
UCL Institute of Health Informatics, United Kingdom (UK) 0.01
Durrer Center for Cardiovascular Research (Durrer Center), Netherlands 0.01
Farr Institute of Health Informatics Research, United Kingdom (UK) 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER